pirtobrutinib,venetoclax,rituximab
roche,eli lilly,abbvie
['bruin', 'lymsm', 'cml']
btki pretreated cohort of mcl pts in bruin study presented by showing promising response rates in this population although unsurprisingly lower than btki naive pts; well tolerated and inclusive of high risk pts #icml23 #17icml #lymsm 
Heme/Onc fellow @UCCancerCenter interested in aggressive lymphoma, novel therapeutics, and cellular therapies #lymsm #TcellRx. Views are my own.